Ergoteles LLC Siga Technologies Inc Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.96 - $9.26 $151,728 - $201,868	-21,800 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.71 - $7.39 $5,139 - $6,651	-900 Reduced 3.96%	21,800 $161,000
Q2 2021 Aug 12, 2021	BUY	$6.1 - $7.58 $138,470 - $172,066	22,700 New	22,700 $143,000
Q1 2021 May 12, 2021	SELL	$6.3 - $7.71 $64,260 - $78,642	-10,200 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$6.39 - $7.76 $17,892 - $21,728	-2,800 Reduced 21.54%	10,200 $74,000
Q3 2020 Nov 16, 2020	BUY	$5.62 - $7.68 $73,060 - $99,840	13,000 New	13,000 $89,000

184

35.6M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $434M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.